NCT00160043View on ClinicalTrials.gov

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

November 30, 2008

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

SH T00268C

1250 mg experimental drug od

DRUG

PTK787/ ZK 222584

1250 mg experimental drug bid (500mg + 750mg)

Trial Locations (6)

37075

Göttingen

45122

Essen

55131

Mainz

75651

Paris

75970

Paris

94805

Villejuif

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY